Genome-wide association study identifies the GLDC/IL33 locus associated with survival of osteosarcoma patients

Roelof Koster, Orestis A. Panagiotou, William A. Wheeler, Eric Karlins, Julie M. Gastier-Foster, Silvia Regina Caminada de Toledo, Antonio S. Petrilli, Adrienne M. Flanagan, Roberto Tirabosco, Irene L. Andrulis, Jay S. Wunder, Nalan Gokgoz, Ana Patiño-Garcia, Fernando Lecanda, Massimo Serra, Claudia Hattinger, Piero Picci, Katia Scotlandi, David M. Thomas, Mandy L. BallingerRichard Gorlick, Donald A. Barkauskas, Logan G. Spector, Margaret Tucker, D. Hicks Belynda, Meredith Yeager, Robert N. Hoover, Sholom Wacholder, Stephen J. Chanock, Sharon A. Savage, Lisa Mirabello

Research output: Contribution to journalArticle

9 Citations (Scopus)

Abstract

Survival rates for osteosarcoma, the most common primary bone cancer, have changed little over the past three decades and are particularly low for patients with metastatic disease. We conducted a multi-institutional genome-wide association study (GWAS) to identify germline genetic variants associated with overall survival in 632 patients with osteosarcoma, including 523 patients of European ancestry and 109 from Brazil. We conducted a time-to-event analysis and estimated hazard ratios (HR) and 95% confidence intervals (CI) using Cox proportional hazards models, with and without adjustment for metastatic disease. The results were combined across the European and Brazilian case sets using a random-effects meta-analysis. The strongest association after meta-analysis was for rs3765555 at 9p24.1, which was inversely associated with overall survival (HR = 1.76; 95% CI 1.41–2.18, p = 4.84 × 10−7). After imputation across this region, the combined analysis identified two SNPs that reached genome-wide significance. The strongest single association was with rs55933544 (HR = 1.9; 95% CI 1.5–2.4; p = 1.3 × 10−8), which localizes to the GLDC gene, adjacent to the IL33 gene and was consistent across both the European and Brazilian case sets. Using publicly available data, the risk allele was associated with lower expression of IL33 and low expression of IL33 was associated with poor survival in an independent set of patients with osteosarcoma. In conclusion, we have identified the GLDC/IL33 locus on chromosome 9p24.1 as associated with overall survival in patients with osteosarcoma. Further studies are needed to confirm this association and shed light on the biological underpinnings of this susceptibility locus.

Original languageEnglish (US)
Pages (from-to)1594-1601
Number of pages8
JournalInternational Journal of Cancer
Volume142
Issue number8
DOIs
StatePublished - Apr 15 2018

Fingerprint

Genome-Wide Association Study
Osteosarcoma
Survival
Confidence Intervals
Meta-Analysis
Bone Neoplasms
Proportional Hazards Models
Genes
Single Nucleotide Polymorphism
Brazil
Survival Rate
Chromosomes
Alleles
Interleukin-33
Genome

Keywords

  • genome-wide association study
  • osteosarcoma
  • osteosarcoma-specific survival
  • overall survival

Cite this

Koster, R., Panagiotou, O. A., Wheeler, W. A., Karlins, E., Gastier-Foster, J. M., Caminada de Toledo, S. R., ... Mirabello, L. (2018). Genome-wide association study identifies the GLDC/IL33 locus associated with survival of osteosarcoma patients. International Journal of Cancer, 142(8), 1594-1601. https://doi.org/10.1002/ijc.31195

Genome-wide association study identifies the GLDC/IL33 locus associated with survival of osteosarcoma patients. / Koster, Roelof; Panagiotou, Orestis A.; Wheeler, William A.; Karlins, Eric; Gastier-Foster, Julie M.; Caminada de Toledo, Silvia Regina; Petrilli, Antonio S.; Flanagan, Adrienne M.; Tirabosco, Roberto; Andrulis, Irene L.; Wunder, Jay S.; Gokgoz, Nalan; Patiño-Garcia, Ana; Lecanda, Fernando; Serra, Massimo; Hattinger, Claudia; Picci, Piero; Scotlandi, Katia; Thomas, David M.; Ballinger, Mandy L.; Gorlick, Richard; Barkauskas, Donald A.; Spector, Logan G.; Tucker, Margaret; Belynda, D. Hicks; Yeager, Meredith; Hoover, Robert N.; Wacholder, Sholom; Chanock, Stephen J.; Savage, Sharon A.; Mirabello, Lisa.

In: International Journal of Cancer, Vol. 142, No. 8, 15.04.2018, p. 1594-1601.

Research output: Contribution to journalArticle

Koster, R, Panagiotou, OA, Wheeler, WA, Karlins, E, Gastier-Foster, JM, Caminada de Toledo, SR, Petrilli, AS, Flanagan, AM, Tirabosco, R, Andrulis, IL, Wunder, JS, Gokgoz, N, Patiño-Garcia, A, Lecanda, F, Serra, M, Hattinger, C, Picci, P, Scotlandi, K, Thomas, DM, Ballinger, ML, Gorlick, R, Barkauskas, DA, Spector, LG, Tucker, M, Belynda, DH, Yeager, M, Hoover, RN, Wacholder, S, Chanock, SJ, Savage, SA & Mirabello, L 2018, 'Genome-wide association study identifies the GLDC/IL33 locus associated with survival of osteosarcoma patients', International Journal of Cancer, vol. 142, no. 8, pp. 1594-1601. https://doi.org/10.1002/ijc.31195
Koster R, Panagiotou OA, Wheeler WA, Karlins E, Gastier-Foster JM, Caminada de Toledo SR et al. Genome-wide association study identifies the GLDC/IL33 locus associated with survival of osteosarcoma patients. International Journal of Cancer. 2018 Apr 15;142(8):1594-1601. https://doi.org/10.1002/ijc.31195
Koster, Roelof ; Panagiotou, Orestis A. ; Wheeler, William A. ; Karlins, Eric ; Gastier-Foster, Julie M. ; Caminada de Toledo, Silvia Regina ; Petrilli, Antonio S. ; Flanagan, Adrienne M. ; Tirabosco, Roberto ; Andrulis, Irene L. ; Wunder, Jay S. ; Gokgoz, Nalan ; Patiño-Garcia, Ana ; Lecanda, Fernando ; Serra, Massimo ; Hattinger, Claudia ; Picci, Piero ; Scotlandi, Katia ; Thomas, David M. ; Ballinger, Mandy L. ; Gorlick, Richard ; Barkauskas, Donald A. ; Spector, Logan G. ; Tucker, Margaret ; Belynda, D. Hicks ; Yeager, Meredith ; Hoover, Robert N. ; Wacholder, Sholom ; Chanock, Stephen J. ; Savage, Sharon A. ; Mirabello, Lisa. / Genome-wide association study identifies the GLDC/IL33 locus associated with survival of osteosarcoma patients. In: International Journal of Cancer. 2018 ; Vol. 142, No. 8. pp. 1594-1601.
@article{686947b9ce8741bda8aaf9845bf2e860,
title = "Genome-wide association study identifies the GLDC/IL33 locus associated with survival of osteosarcoma patients",
abstract = "Survival rates for osteosarcoma, the most common primary bone cancer, have changed little over the past three decades and are particularly low for patients with metastatic disease. We conducted a multi-institutional genome-wide association study (GWAS) to identify germline genetic variants associated with overall survival in 632 patients with osteosarcoma, including 523 patients of European ancestry and 109 from Brazil. We conducted a time-to-event analysis and estimated hazard ratios (HR) and 95{\%} confidence intervals (CI) using Cox proportional hazards models, with and without adjustment for metastatic disease. The results were combined across the European and Brazilian case sets using a random-effects meta-analysis. The strongest association after meta-analysis was for rs3765555 at 9p24.1, which was inversely associated with overall survival (HR = 1.76; 95{\%} CI 1.41–2.18, p = 4.84 × 10−7). After imputation across this region, the combined analysis identified two SNPs that reached genome-wide significance. The strongest single association was with rs55933544 (HR = 1.9; 95{\%} CI 1.5–2.4; p = 1.3 × 10−8), which localizes to the GLDC gene, adjacent to the IL33 gene and was consistent across both the European and Brazilian case sets. Using publicly available data, the risk allele was associated with lower expression of IL33 and low expression of IL33 was associated with poor survival in an independent set of patients with osteosarcoma. In conclusion, we have identified the GLDC/IL33 locus on chromosome 9p24.1 as associated with overall survival in patients with osteosarcoma. Further studies are needed to confirm this association and shed light on the biological underpinnings of this susceptibility locus.",
keywords = "genome-wide association study, osteosarcoma, osteosarcoma-specific survival, overall survival",
author = "Roelof Koster and Panagiotou, {Orestis A.} and Wheeler, {William A.} and Eric Karlins and Gastier-Foster, {Julie M.} and {Caminada de Toledo}, {Silvia Regina} and Petrilli, {Antonio S.} and Flanagan, {Adrienne M.} and Roberto Tirabosco and Andrulis, {Irene L.} and Wunder, {Jay S.} and Nalan Gokgoz and Ana Pati{\~n}o-Garcia and Fernando Lecanda and Massimo Serra and Claudia Hattinger and Piero Picci and Katia Scotlandi and Thomas, {David M.} and Ballinger, {Mandy L.} and Richard Gorlick and Barkauskas, {Donald A.} and Spector, {Logan G.} and Margaret Tucker and Belynda, {D. Hicks} and Meredith Yeager and Hoover, {Robert N.} and Sholom Wacholder and Chanock, {Stephen J.} and Savage, {Sharon A.} and Lisa Mirabello",
year = "2018",
month = "4",
day = "15",
doi = "10.1002/ijc.31195",
language = "English (US)",
volume = "142",
pages = "1594--1601",
journal = "International Journal of Cancer",
issn = "0020-7136",
publisher = "Wiley-Liss Inc.",
number = "8",

}

TY - JOUR

T1 - Genome-wide association study identifies the GLDC/IL33 locus associated with survival of osteosarcoma patients

AU - Koster, Roelof

AU - Panagiotou, Orestis A.

AU - Wheeler, William A.

AU - Karlins, Eric

AU - Gastier-Foster, Julie M.

AU - Caminada de Toledo, Silvia Regina

AU - Petrilli, Antonio S.

AU - Flanagan, Adrienne M.

AU - Tirabosco, Roberto

AU - Andrulis, Irene L.

AU - Wunder, Jay S.

AU - Gokgoz, Nalan

AU - Patiño-Garcia, Ana

AU - Lecanda, Fernando

AU - Serra, Massimo

AU - Hattinger, Claudia

AU - Picci, Piero

AU - Scotlandi, Katia

AU - Thomas, David M.

AU - Ballinger, Mandy L.

AU - Gorlick, Richard

AU - Barkauskas, Donald A.

AU - Spector, Logan G.

AU - Tucker, Margaret

AU - Belynda, D. Hicks

AU - Yeager, Meredith

AU - Hoover, Robert N.

AU - Wacholder, Sholom

AU - Chanock, Stephen J.

AU - Savage, Sharon A.

AU - Mirabello, Lisa

PY - 2018/4/15

Y1 - 2018/4/15

N2 - Survival rates for osteosarcoma, the most common primary bone cancer, have changed little over the past three decades and are particularly low for patients with metastatic disease. We conducted a multi-institutional genome-wide association study (GWAS) to identify germline genetic variants associated with overall survival in 632 patients with osteosarcoma, including 523 patients of European ancestry and 109 from Brazil. We conducted a time-to-event analysis and estimated hazard ratios (HR) and 95% confidence intervals (CI) using Cox proportional hazards models, with and without adjustment for metastatic disease. The results were combined across the European and Brazilian case sets using a random-effects meta-analysis. The strongest association after meta-analysis was for rs3765555 at 9p24.1, which was inversely associated with overall survival (HR = 1.76; 95% CI 1.41–2.18, p = 4.84 × 10−7). After imputation across this region, the combined analysis identified two SNPs that reached genome-wide significance. The strongest single association was with rs55933544 (HR = 1.9; 95% CI 1.5–2.4; p = 1.3 × 10−8), which localizes to the GLDC gene, adjacent to the IL33 gene and was consistent across both the European and Brazilian case sets. Using publicly available data, the risk allele was associated with lower expression of IL33 and low expression of IL33 was associated with poor survival in an independent set of patients with osteosarcoma. In conclusion, we have identified the GLDC/IL33 locus on chromosome 9p24.1 as associated with overall survival in patients with osteosarcoma. Further studies are needed to confirm this association and shed light on the biological underpinnings of this susceptibility locus.

AB - Survival rates for osteosarcoma, the most common primary bone cancer, have changed little over the past three decades and are particularly low for patients with metastatic disease. We conducted a multi-institutional genome-wide association study (GWAS) to identify germline genetic variants associated with overall survival in 632 patients with osteosarcoma, including 523 patients of European ancestry and 109 from Brazil. We conducted a time-to-event analysis and estimated hazard ratios (HR) and 95% confidence intervals (CI) using Cox proportional hazards models, with and without adjustment for metastatic disease. The results were combined across the European and Brazilian case sets using a random-effects meta-analysis. The strongest association after meta-analysis was for rs3765555 at 9p24.1, which was inversely associated with overall survival (HR = 1.76; 95% CI 1.41–2.18, p = 4.84 × 10−7). After imputation across this region, the combined analysis identified two SNPs that reached genome-wide significance. The strongest single association was with rs55933544 (HR = 1.9; 95% CI 1.5–2.4; p = 1.3 × 10−8), which localizes to the GLDC gene, adjacent to the IL33 gene and was consistent across both the European and Brazilian case sets. Using publicly available data, the risk allele was associated with lower expression of IL33 and low expression of IL33 was associated with poor survival in an independent set of patients with osteosarcoma. In conclusion, we have identified the GLDC/IL33 locus on chromosome 9p24.1 as associated with overall survival in patients with osteosarcoma. Further studies are needed to confirm this association and shed light on the biological underpinnings of this susceptibility locus.

KW - genome-wide association study

KW - osteosarcoma

KW - osteosarcoma-specific survival

KW - overall survival

UR - http://www.scopus.com/inward/record.url?scp=85039558922&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85039558922&partnerID=8YFLogxK

U2 - 10.1002/ijc.31195

DO - 10.1002/ijc.31195

M3 - Article

C2 - 29210060

AN - SCOPUS:85039558922

VL - 142

SP - 1594

EP - 1601

JO - International Journal of Cancer

JF - International Journal of Cancer

SN - 0020-7136

IS - 8

ER -